Press release: New live attenuated TB vaccine is safe and shows a distinct, dose dependent immune response in a Phase1b trial in newborns
The initial results of the Phase 1b study have been presented at the 5th Global Forum on TB vaccines in Delhi. Please read the press release.
A new TB vaccine is an inevitability; the question is how long will it take us to get there? Please read the article about progress and challenges in TB vaccine development.
From 29 January – 1 February 2018 the TBVI symposium and TBVAC2020 annual meeting took place in Les Diablerets, Switzerland. This yearly event was attended by over 140 participants from 70 [...]